Position Statement of the Italian Society of Cardiovascular Prevention (SIPREC) and Italian Heart Failure Association (ITAHFA) on Cardiac Rehabilitation and Protection Programs as a Cornerstone of Secondary Prevention after Myocardial Infarction or Revascularization.
Cardiac rehabilitation
Cardiovascular prevention
Coronary artery disease
Myocardial infarction
Physical exercise
Journal
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension
ISSN: 1179-1985
Titre abrégé: High Blood Press Cardiovasc Prev
Pays: New Zealand
ID NLM: 9421087
Informations de publication
Date de publication:
26 Jul 2024
26 Jul 2024
Historique:
received:
24
06
2024
accepted:
12
07
2024
medline:
27
7
2024
pubmed:
27
7
2024
entrez:
26
7
2024
Statut:
aheadofprint
Résumé
Despite the remarkable and progressive advances made in the prevention and management of cardiovascular diseases, the recurrence of cardiovascular events remains unacceptably elevated with a notable size of the residual risk. Indeed, in patients who suffered from myocardial infarction or who underwent percutaneous or surgical myocardial revascularization, life-style changes and optimized pharmacological therapy with antiplatelet drugs, lipid lowering agents, beta-blockers, renin angiotensin system inhibitors and antidiabetic drugs, when appropriate, are systematically prescribed but they might be insufficient to protect from further events. In such a context, an increasing body of evidence supports the benefits of cardiac rehabilitation (CR) in the setting of secondary cardiovascular prevention, consisting in the reduction of myocardial oxygen demands, in the inhibition of atherosclerotic plaque progression and in an improvement of exercise performance, quality of life and survival. However, prescription and implementation of CR programs is still not sufficiently considered.The aim of this position paper of the Italian Society of Cardiovascular Prevention (SIPREC) and of the Italian Heart Failure Association (ITAHFA) is to examine the reasons of the insufficient use of this strategy in clinical practice and to propose some feasible solutions to overcome this clinical gap.
Identifiants
pubmed: 39060868
doi: 10.1007/s40292-024-00663-z
pii: 10.1007/s40292-024-00663-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Italian Ministry of Health (Ricerca Corrente)
ID : Italian Ministry of Health (Ricerca Corrente)
Informations de copyright
© 2024. The Author(s).
Références
Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, et al. European society of cardiology: cardiovascular disease statistics 2021. Eur Heart J. 2022;43:716–99.
pubmed: 35016208
doi: 10.1093/eurheartj/ehab892
Gomez-Delgado F, Raya-Cruz M, Katsiki N, Delgado-Lista J, Perez-Martinez P. Residual cardiovascular risk: when should we treat it? Eur J Intern Med. 2024;120:17–24.
pubmed: 37845117
doi: 10.1016/j.ejim.2023.10.013
Makover ME, Surma S, Banach M, Toth PP. Eliminating atherosclerotic cardiovascular disease residual risk. Eur Heart J. 2023;44(45):4731–3.
pubmed: 37448228
doi: 10.1093/eurheartj/ehad446
Matsuura Y, Kanter JE, Bornfeldt KE. Highlighting residual atherosclerotic cardiovascular disease risk. Arterioscler Thromb Vasc Biol. 2019;39(1):e1–9.
pubmed: 30586334
pmcid: 6310032
doi: 10.1161/ATVBAHA.118.311999
Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, ESC National Cardiac Societies; ESC Scientific Document Group, et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227–337.
pubmed: 34458905
doi: 10.1093/eurheartj/ehab484
Volpe M, Presta V. Inflammatory residual risk: an emerging target to reduce cardiovascular disease? Clin Cardiol. 2018;41(4):437–9.
pubmed: 29693720
pmcid: 6489727
doi: 10.1002/clc.22885
Kronenberg F, Mora S, Stroes ESG, Ference BA, Arsenault BJ, Berglund L, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European atherosclerosis society consensus statement. Eur Heart J. 2022;43:3925–46.
pubmed: 36036785
pmcid: 9639807
doi: 10.1093/eurheartj/ehac361
Sniderman AD, Navar AM, Thanassoulis G, Apolipoprotein B. vs. low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol as the primary measure of apolipoprotein B lipoprotein-related risk: the debate is over. JAMA Cardiol. 2022;7:257–8.
pubmed: 34773457
doi: 10.1001/jamacardio.2021.5080
Patel KV, Pandey A, de Lemos JA. Conceptual Framework for addressing residual atherosclerotic cardiovascular disease risk in the era of Precision Medicine. Circulation. 2018;137(24):2551–3.
pubmed: 29643058
doi: 10.1161/CIRCULATIONAHA.118.035289
Ades PA, Keteyian SJ, Wright JS, Hamm LF, Lui K, Newlin K, Shepard DS, Thomas RJ. Increasing cardiac rehabilitation participation from 20–70%: a road map from the million hearts cardiac rehabilitation collaborative. Mayo Clin Proc. 2017;92(2):234–242.
Ambrosetti M, Abreu A, Corrà U, Davos CH, Hansen D, Frederix I, Iliou MC, Pedretti RFE, Schmid JP, Vigorito C, Voller H, Wilhelm M, Piepoli MF, Bjarnason-Wehrens B, Berger T, Cohen-Solal A, Cornelissen V, Dendale P, Doehner W, Gaita D, Gevaert AB, Kemps H, Kraenkel N, Laukkanen J, Mendes M, Niebauer J, Simonenko M, Zwisler AO. Secondary prevention through comprehensive cardiovascular rehabilitation: from knowledge to implementation. 2020 update. A position paper from the secondary prevention and rehabilitation section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2021;28(5):460–95.
pubmed: 33611446
doi: 10.1177/2047487320913379
Armstrong N, Barker AR. Endurance training and elite young athletes. Med Sport Sci. 2011;56:59–83.
pubmed: 21178367
doi: 10.1159/000320633
American College of Sports Medicine. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc. 2009;41(3):687–708.
doi: 10.1249/MSS.0b013e3181915670
Buchheit M, Laursen PB. High-intensity interval training, solutions to the programming puzzle: part I: cardiopulmonary emphasis. Sports Med. 2013;43(5):313–3.
pubmed: 23539308
doi: 10.1007/s40279-013-0029-x
Tinken TM, Thijssen DH, Hopkins N, Dawson EA, Cable NT, Green DJ. Shear stress mediates endothelial adaptations to exercise training in humans. Hypertension. 2010;55(2):312–8.
pubmed: 20048193
doi: 10.1161/HYPERTENSIONAHA.109.146282
Iellamo F, Perrone MA, Caminiti G, Volterrani M, Legramante JM. Post-exercise hypotension in patients with coronary artery disease. Front Physiol. 2021;12:788591.
pubmed: 35002770
pmcid: 8727444
doi: 10.3389/fphys.2021.788591
Caminiti G, Iellamo F, Mancuso A, Cerrito A, Montano M, Manzi V, Volterrani M. Effects of 12 weeks of aerobic versus combined aerobic plus resistance exercise training on short-term blood pressure variability in patients with hypertension. J Appl Physiol (1985). 2021;130(4):1085–92.
pubmed: 33630677
doi: 10.1152/japplphysiol.00910.2020
Myers J. Cardiology patient pages. Exercise and cardiovascular health. Circulation. 2003;107(1):e2–5.
pubmed: 12515760
doi: 10.1161/01.CIR.0000048890.59383.8D
Biffi A, Gallo G, Fernando F, Sirico F, Signorello MG, De Martino L, Manole GE, Palermi S, Volpe M. Relationship between cardiorespiratory fitness, baseline blood pressure and hypertensive response to exercise in the ferrari corporate population. High Blood Press Cardiovasc Prev. 2022;29(1):81–8.
pubmed: 34822139
doi: 10.1007/s40292-021-00491-5
Bruning RS, Sturek M. Benefits of exercise training on coronary blood flow in coronary artery disease patients. Prog Cardiovasc Dis. 2015;57(5):443–53.
Quindry JC, Franklin BA. Exercise preconditioning as a cardioprotective phenotype. Am J Cardiol. 2021;148:8–15.
pubmed: 33675772
doi: 10.1016/j.amjcard.2021.02.030
Church TS, Lavie CJ, Milani RV, Kirby GS. Improvements in blood rheology after cardiac rehabilitation and exercise training in patients with coronary heart disease. Am Heart J. 2002;143:349–55.
pubmed: 11835042
doi: 10.1067/mhj.2002.119758
Elsayegh AT, Karim K, Shabana A. Impact of cardiac rehabilitation programs post primary percutaneous coronary intervention on functional capacity and metabolic profile through different age groups. High Blood Press Cardiovasc Prev. 2023;30(2):145–50.
pubmed: 36757672
doi: 10.1007/s40292-023-00566-5
Hurdus B, Munyombwe T, Dondo TB, Aktaa S, Oliver G, Hall M, Doherty P, Hall AS, Gale CP. Association of cardiac rehabilitation and health-related quality of life following acute myocardial infarction. Heart. 2020;106(22):1726–31.
pubmed: 32826289
doi: 10.1136/heartjnl-2020-316920
Campos HO, Rodrigues QT, Drummond LR, Lima PMA, Monteiro MDC, Wanner SP, Coimbra CC. Exercise-based cardiac rehabilitation after myocardial revascularization: a systematic review and meta-analysis. Rev Cardiovasc Med. 2022;23(2):74.
pubmed: 35229565
doi: 10.31083/j.rcm2302074
Hambrecht R, Walther C, Möbius-Winkler S, Gielen S, Linke A, Conradi K, Erbs S, Kluge R, Kendziorra K, Sabri O, Sick P, Schuler G. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation. 2004;109(11):1371–8.
pubmed: 15007010
doi: 10.1161/01.CIR.0000121360.31954.1F
Suaya JA, Stason WB, Ades PA, Normand SL, Shepard DS. Cardiac rehabilitation and survival in older coronary patients. J Am Coll Cardiol. 2009;54(1):25–33.
pubmed: 19555836
doi: 10.1016/j.jacc.2009.01.078
Jolliffe JA, Rees K, Taylor RS, Thompson D, Oldridge N, Ebrahim S. Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2001;(1):CD001800. https://doi.org/10.1002/14651858.CD001800 . Update in: Cochrane Database Syst Rev. 2011;(7):CD001800.
Anderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, Taylor RS. Exercise-based cardiac rehabilitation for coronary heart disease: cochrane systematic review and meta-analysis. J Am Coll Cardiol. 2016;67(1):1–12.
pubmed: 26764059
doi: 10.1016/j.jacc.2015.10.044
Dibben GO, Faulkner J, Oldridge N, Rees K, Thompson DR, Zwisler AD, Taylor RS. Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis. Eur Heart J. 2023;44(6):452–69.
pubmed: 36746187
pmcid: 9902155
doi: 10.1093/eurheartj/ehac747
Hastings MH, Castro C, Freeman R et al. Intrinsic and extrinsic contributors to the cardiac benefits of exercise. JACC: Basic to Transitional Science. 2023. https://doi.org/10.1016/j.jacbts.2023.07.011
Port S, McEwan P, Cobb FR, Jones RH. Influence of resting left ventricular function on the left ventricular response to exercise in patients with coronary artery disease. Circulation. 1981;63:856–63.
pubmed: 7471342
doi: 10.1161/01.CIR.63.4.856
Höllriegel R, Winzer EB, Linke A, et al. Long-term exercise training in patients with advanced chronic heart failure: sustained benefits on left ventricular performance and exercise capacity. J Cardiopulm Rehabil Prev. 2016;36:117–24.
pubmed: 26906148
doi: 10.1097/HCR.0000000000000165
Besnier F, Labrunée M, Richard L, et al. Short-term effects of a 3-week interval training program on heart rate variability in chronic heart failure. A randomised controlled trial. Ann Phys Rehabil Med. 2019;62:321–8.
pubmed: 31352063
doi: 10.1016/j.rehab.2019.06.013
Erbs S, Höllriegel R, Linke A, et al. Exercise training in patients with advanced chronic heart failure (NYHA IIIb) promotes restoration of peripheral vasomotor function, induction of endogenous regeneration, and improvement of left ventricular function. Circ Heart Fail. 2010;3:486–94.
pubmed: 20430934
doi: 10.1161/CIRCHEARTFAILURE.109.868992
Hosseini Mohammadi NS, Shaki Katouli MH, Masoudkabir F, Meysamie A, Tavakoli K, Vasheghani-Farahani A. Cardiac rehabilitation in heart failure with severely reduced ejection fraction: effects on mortality. Heart Fail Rev. 2023;28:1–19.
pubmed: 35596876
doi: 10.1007/s10741-022-10242-w
Molloy CD. Updated cochrane systematic review and meta-analysis of exercise-based cardiac rehabilitation in adults with heart failure: a subgroup analysis of delivery mode. Heart. 2022;108:A14.
Thomas RJ, Balady G, Banka G, Beckie TM, Chiu J, Gokak S, Ho PM, Keteyian SJ, King M, Lui K, Pack Q, Sanderson BK, Wang TY. 2018 ACC/AHA clinical performance and quality measures for cardiac rehabilitation: a report of the American College of Cardiology/American Heart Association Task Force on performance measures. J Am Coll Cardiol. 2018;71(16):1814–37.
pubmed: 29606402
doi: 10.1016/j.jacc.2018.01.004
Bracewell NJ, Plasschaert J, Conti CR, Keeley EC, Conti JB. Cardiac rehabilitation: effective yet underutilized in patients with cardiovascular disease. Clin Cardiol. 2022;45(11):1128–34.
pubmed: 36054282
pmcid: 9707561
doi: 10.1002/clc.23911
Chindhy S, Taub PR, Lavie CJ, Shen J. Current challenges in cardiac rehabilitation: strategies to overcome social factors and attendance barriers. Expert Rev Cardiovasc Ther. 2020;18(11):777–89.
pubmed: 32885702
pmcid: 7749053
doi: 10.1080/14779072.2020.1816464
Beatty AL, Beckie TM, Dodson J, Goldstein CM, Hughes JW, Kraus WE, Martin SS, Olson TP, Pack QR, Stolp H, Thomas RJ, Wu WC, Franklin BA. A new era in cardiac rehabilitation delivery: research gaps, questions, strategies, and priorities. Circulation. 2023;147(3):254–66.
pubmed: 36649394
pmcid: 9988237
doi: 10.1161/CIRCULATIONAHA.122.061046
Thompson DR, Ski CF, Clark AM. Cardiac rehabilitation and secondary prevention: wrong terms, aims, models and outcomes? Eur J Prev Cardiol. 2019;26(9):995–7.
pubmed: 30813815
doi: 10.1177/2047487319834385
Ruivo J, Moholdt T, Abreu A. Overview of cardiac rehabilitation following post-acute myocardial infarction in European Society of Cardiology member countries. Eur J Prev Cardiol. 2023;30(9):758–68.
pubmed: 36722203
doi: 10.1093/eurjpc/zwad024
Golbus JR, Lopez-Jimenez F, Barac A, Cornwell WK 3rd, Dunn P, Forman DE, Martin SS, Schorr EN, Supervia M. Exercise, Cardiac Rehabilitation and Secondary Prevention Committee of the Council on Clinical Cardiology; Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Quality of Care and Outcomes Research; and Council on Cardiovascular and Stroke Nursing. Digital Technologies in Cardiac Rehabilitation: a science advisory from the American Heart Association. Circulation. 2023;148(1):95–107.
pubmed: 37272365
doi: 10.1161/CIR.0000000000001150
Widmer RJ, Allison TG, Lennon R, Lopez-Jimenez F, Lerman LO, Lerman A. Digital health intervention during cardiac rehabilitation: a randomized controlled trial. Am Heart J. 2017;188:65–72.
pubmed: 28577682
doi: 10.1016/j.ahj.2017.02.016
Imran TF, Wang N, Zombeck S, Balady GJ. Mobile technology improves adherence to cardiac rehabilitation: a propensity score-matched study. J Am Heart Assoc. 2021;10(15):e020482.
pubmed: 34278801
pmcid: 8475674
doi: 10.1161/JAHA.120.020482
Aharon KB, Gershfeld-Litvin A, Amir O, Nabutovsky I, Klempfner R. Improving cardiac rehabilitation patient adherence via personalized interventions. PLoS ONE. 2022;17(8):e0273815.
pubmed: 36037232
pmcid: 9423647
doi: 10.1371/journal.pone.0273815
Vahedian-Azimi A, Sanjari MJ, Rahimi-Bashar F, Gohari-Mogadam K, Ouahrani A, Mustafa EMM, Ait Hssain A, Sahebkar A. Cardiac rehabilitation using the family-centered empowerment model is effective in improving long-term mortality in patients with myocardial infarction: a 10-year follow-up randomized clinical trial. High Blood Press Cardiovasc Prev. 2024;31(2):189–204.
pubmed: 38564167
doi: 10.1007/s40292-024-00636-2
Conte M, Morisco C, Rozza F, De Luca N, Mancusi C. Medical assistance in contextual awareness (AMICO): a project for a better quality of care for patients in cardiac rehabilitation unit. High Blood Press Cardiovasc Prev. 2022;29(3):305–9.
pubmed: 35314963
doi: 10.1007/s40292-022-00512-x
Claes J, Kuznetsova T, Cauwenberghs N, Cornelissen V. The changing landscape of cardiac rehabilitation and the power of personalized therapy. Front Cardiovasc Med. 2024;11:1393217.
pubmed: 38699581
pmcid: 11063310
doi: 10.3389/fcvm.2024.1393217
Battistoni A, Tocci G, Gallo G, Solfanelli G, Volpe M. A mobile app-based approach in cardiovascular disease prevention: a prospective randomized study. High Blood Press Cardiovasc Prev. 2024;31(1):93–9.
pubmed: 38416388
pmcid: 10925561
doi: 10.1007/s40292-024-00625-5
Gallo G, Autore C, Volterrani M, Barbato E, Volpe M. Monitoring the effects of cardiac rehabilitation programs in heart failure patients: the role of biomarkers. Submitted, under review.
Taylor RS, Dalal HM, McDonagh STJ. The role of cardiac rehabilitation in improving cardiovascular outcomes. Nat Rev Cardiol. 2022;19(3):180–94.
pubmed: 34531576
doi: 10.1038/s41569-021-00611-7